Share
7,280 Posts.
lightbulb Created with Sketch. 447
clock Created with Sketch. 07/10/21
12:37
Share
Originally posted by camban
↑
Actually, re-reading this press release enrages me. They are spinning this like it’s a positive: “...one step closer to approval”. Even just a regular small time investor in US pharma/biotech knows that receipt of a CRL from the FDA is the worst possible outcome. A CRL is a formal decision not a step in the process, and Scott well knows this. Most stocks get absolutely smashed after a CRL - in recent months I’ve seen anywhere from 50-80% plunges in the share price within minutes of news that a CRL has been issued. For many drug companies it’s the end of the road for that drug.
Expand
Price action tells that market was not expecting any thing from this and it has already written off this product.
(20min delay)